Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35527484)

  • 1. [METTL27 is a prognostic biomarker of colon cancer and associated with immune invasion].
    Wang K; Zhang J; Deng M; Ju Y; Ouyang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):486-497. PubMed ID: 35527484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration.
    Lu Y; Wang K; Peng Y; Zhang J; Ju Q; Xu Q; Ouyang M; He Z
    PeerJ; 2023; 11():e16334. PubMed ID: 38025742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma].
    Zhao H; Liu G; Li Y; Yang N; Zhao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
    BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
    Ren Y; Lv Y; Li T; Jiang Q
    Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling.
    Han R; Feng P; Pang J; Zou D; Li X; Geng C; Li L; Min J; Shi J
    Front Oncol; 2021; 11():700972. PubMed ID: 34282404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDC1 is a Prognostic Biomarker and Associated with Immune Infiltrates in Colon Cancer.
    Liu M; Yuan R; Liu S; Xue Y; Wang X
    Int J Gen Med; 2021; 14():8811-8817. PubMed ID: 34858049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis.
    Zhang JR; Hou P; Wang XJ; Weng ZQ; Shang-Guan XC; Wang H; You F; Lin BQ; Huang ZY; Chen XQ
    Front Immunol; 2021; 12():742358. PubMed ID: 34938284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 11. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
    Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
    Front Genet; 2022; 13():821826. PubMed ID: 35664320
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of immune infiltration-related LncRNA FAM83C-AS1 for predicting prognosis and immunotherapy response in colon cancer.
    Li G; Feng H; Chen Q; Xue C; Li M; Liu X; Ma S
    Transpl Immunol; 2021 Dec; 69():101481. PubMed ID: 34624486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ULBP2 is a biomarker related to prognosis and immunity in colon cancer.
    Yang X; Su X; Wang Z; Yu Y; Wu Z; Zhang D
    Mol Cell Biochem; 2023 Oct; 478(10):2207-2219. PubMed ID: 36633827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
    Dai K; Liu C; Guan G; Cai J; Wu L
    BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer.
    Luo H; Luo J; Ding N; Zhang T; He Y
    Pharmgenomics Pers Med; 2023; 16():1109-1126. PubMed ID: 38149287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
    Hu M; Gu J; Su W; Zhang Z; Zhu B; Wang Q; Xing C
    Biomed Res Int; 2021; 2021():4896106. PubMed ID: 34888380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.